Tag: M.B.B.S., Raghu Kalluri, M.D., Ph.D.

First-in-class pan-KRAS inhibitor shows strong antitumor activity in preclinical models

Added to Collection on: 2025-09-03 19:15:02

Tags for this article:

Click the tags to see associated articles and topics

View Article Details Create a Dashboard with this Tag